{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:33:07Z","timestamp":1759969987835,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.ijpharm.2011.03.010","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T04:29:35Z","timestamp":1300249775000},"page":"106-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system"],"prefix":"10.1016","volume":"412","author":[{"given":"Golam","family":"Kibria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyoshi","family":"Harashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2011.03.010_bib0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/n35101999","article-title":"Identification of the cellular receptor for anthrax toxin","volume":"414","author":"Bradley","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0010","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1128\/IAI.67.2.964-967.1999","article-title":"Functional analysis of the carboxy-terminal domain of Bacillus anthracis protective antigen","volume":"67","author":"Brossier","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0015","doi-asserted-by":"crossref","first-page":"12905","DOI":"10.1074\/jbc.M900280200","article-title":"Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors","volume":"284","author":"Chang","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0020","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1196\/annals.1322.011","article-title":"Tumor vascular targeting with tumor necrosis factor alpha and chemotherapeutic drugs","volume":"1028","author":"Corti","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0025","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jconrel.2009.08.011","article-title":"Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel","volume":"140","author":"Danhier","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0030","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00259-006-0180-9","article-title":"Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides","volume":"34","author":"Dijkgraaf","year":"2007","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0035","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1124\/jpet.107.122481","article-title":"Cyclic Arg-Gly-Asp peptide-labeled liposomes for targeting drug therapy of hepatic fibrosis in rats","volume":"322","author":"Du","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1208\/s12248-008-9071-2","article-title":"Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment","volume":"11","author":"El-Sayed","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0045","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/CAD.0b013e3282a213ce","article-title":"Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects","volume":"18","author":"Garde","year":"2007","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1083\/jcb.121.1.61","article-title":"Clathrin and HA2 adaptors: effects of potassium depletion, hypertonic medium, and cytosol acidification","volume":"121","author":"Hansen","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0055","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijpharm.2007.04.037","article-title":"Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes","volume":"342","author":"Hatakeyama","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0060","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1083\/jcb.108.2.389","article-title":"Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation","volume":"108","author":"Heuser","year":"1989","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0065","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1083\/jcb.124.5.689","article-title":"The coated pit and macropinocytic pathways serve distinct endosome populations","volume":"124","author":"Hewlett","year":"1994","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0070","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1023\/A:1010960900254","article-title":"Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo","volume":"18","author":"Ishida","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0075","first-page":"21","article-title":"Bacillus anthracis evolution and epidemiology","volume":"271","author":"Keim","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0080","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/sj.gt.3302128","article-title":"Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation","volume":"11","author":"Khalil","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0085","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jconrel.2004.04.024","article-title":"Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method","volume":"98","author":"Kogure","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0090","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0955-0674(95)80015-8","article-title":"The emergence of clathrin-independent pinocytic pathways","volume":"7","author":"Lamaze","year":"1995","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0095","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/380561a0","article-title":"Doxorubicin in sterically stabilized liposomes","volume":"380","author":"Lasic","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1586\/14737140.8.3.331","article-title":"Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer","volume":"8","author":"Minisini","year":"2008","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0105","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1034\/j.1399-3011.2000.00723.x","article-title":"Polyarginine enters cells more efficiently than other polycationic homopolymers","volume":"56","author":"Mitchell","year":"2000","journal-title":"J. Pept. Res."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0225","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jconrel.2007.10.020","article-title":"A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway","volume":"125","author":"Mudhakir","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0115","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jconrel.2007.03.010","article-title":"Octaarginine-modified multifunctional envelope-type nano device for siRNA","volume":"119","author":"Nakamura","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jconrel.2008.09.008","article-title":"In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells","volume":"133","author":"Ogawara","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0125","first-page":"7400","article-title":"Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy","volume":"63","author":"Pastorino","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1081\/CNV-120014883","article-title":"Pegylated liposomal doxorubicin (Doxil) for metastatic breast cancer: the Cancer Research Network Inc., experience","volume":"20","author":"Perez","year":"2002","journal-title":"Cancer Invest."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0135","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/385833a0","article-title":"Crystal structure of the anthrax toxin protective antigen","volume":"385","author":"Petosa","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0140","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i6.10","article-title":"Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic","volume":"26","author":"Puri","year":"2009","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"year":"2002","series-title":"Cell-Penetrating Peptides: Processes and Applications","author":"Rothbard","key":"10.1016\/j.ijpharm.2011.03.010_bib0145"},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0150","first-page":"3743","article-title":"Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug or drug-containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts","volume":"56","author":"Sakakibara","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0155","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.mib.2004.12.005","article-title":"Interactions between anthrax toxin receptors and protective antigen","volume":"8","author":"Scobie","year":"2005","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0160","first-page":"1439","article-title":"Doxil\u2014pegylated liposomal doxorubicin","volume":"35","author":"Sekiya","year":"2008","journal-title":"Gan. To. Kagaku. Ryoho."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0165","doi-asserted-by":"crossref","first-page":"15493","DOI":"10.1016\/S0021-9258(18)98643-6","article-title":"The carboxyl-terminal end of protective antigen is required for receptor binding and anthrax toxin activity","volume":"266","author":"Singh","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0076-6879(04)87003-4","article-title":"Folate receptor-mediated targeting of liposomal drugs to cancer cells","volume":"387","author":"Stephenson","year":"2004","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0175","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2007.06.010","article-title":"Effective anti-tumor activity of oxaliplatin encapsulated in transferrin\u2013PEG\u2013liposome","volume":"346","author":"Suzuki","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0180","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1248\/bpb.30.758","article-title":"Efficient cytoplasmic protein delivery by means of a multifunctional envelope-type nano device","volume":"30","author":"Suzuki","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0185","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2010.05.002","article-title":"Design of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake","volume":"396","author":"Takara","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0190","first-page":"1","article-title":"Introduction: anthrax history, disease and ecology","volume":"271","author":"Turnbull","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0195","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1128\/IAI.67.4.1860-1865.1999","article-title":"Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin","volume":"67","author":"Varughese","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0200","doi-asserted-by":"crossref","first-page":"13003","DOI":"10.1073\/pnas.97.24.13003","article-title":"The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters","volume":"97","author":"Wender","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0205","doi-asserted-by":"crossref","first-page":"23227","DOI":"10.1074\/jbc.M603676200","article-title":"Anthrax toxin receptor 1\/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton","volume":"281","author":"Werner","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0210","doi-asserted-by":"crossref","first-page":"723798","DOI":"10.1155\/2010\/723798","article-title":"Peptide-mediated liposomal drug delivery system targeting tumor blood vessels in anticancer therapy","volume":"2010","author":"Wu","year":"2010","journal-title":"J. Oncol."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0215","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1158\/1078-0432.CCR-08-0159","article-title":"Design of folate-linked liposomal doxorubicin to its antitumor effect in mice","volume":"14","author":"Yamada","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijpharm.2011.03.010_bib0220","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev.biochem.75.103004.142728","article-title":"Anthrax toxin: receptor binding, internalization, pore formation, and translocation","volume":"76","author":"Young","year":"2007","journal-title":"Annu. Rev. Biochem."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517311002122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517311002122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:27:02Z","timestamp":1759915622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517311002122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":44,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0378517311002122"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2011.03.010","relation":{},"ISSN":["0378-5173"],"issn-type":[{"type":"print","value":"0378-5173"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2011.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}